Vaxart, Inc. Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions
Vaxart, Inc. (VXRT) reported Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions of $9.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-15.
Discontinued › Notes › Income Taxes
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions · last filed 2023-03-15
- Vaxart, Inc. unrecognized tax benefits, increase resulting from prior period tax positions for fiscal 2021 was $9.00K.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions 12 month |
|---|---|
| 2021-12-31 | $9.00K 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |